作为迈克尔受体产药的5-氧γ-皮龙的机械分析
Clifford Leung1, Umyeena M Bashir1, William L Karney1
1Department of Chemistry, University of San Francisco, San Francisco, California 94117, United States.
The Journal of organic chemistry
|August 23, 2024
概括
替代的5-基 γ-皮龙具有作为共价抑制剂的潜力. 新的研究揭示了水解和酶抑制的独特途径,使合理的药物优化成为可能.
科学领域:
- 药用化学 医学化学
- 化学生物学 化学生物学
- 生物化学 生物化学
背景情况:
- 替代的5-基 γ-皮龙是有前途的共价抑制剂.
- 水解不稳定性阻碍了这些化合物的优化.
- 以前的机制提出了迈克尔接受者前药物行为.
研究的目的:
- 为了阐明替代的5-氧γ-pyrones的作用机制.
- 研究水解和酶抑制的不同途径.
- 为了指导这些共价抑制剂的合理优化.
主要方法:
- 运动核磁共振 (NMR) 实验.
- 哈梅特分析. 哈梅特分析.
- 动态同位素效应研究.
- 密度函数理论 (DFT) 的计算.
主要成果:
- 酶抑制和水解通过不同的机械路径进行.
- 替代电子不同影响水解和抑制.
- 这些发现挑战了先前的机制性建议.
结论:
- 建议对替代的5-基 γ-pyrones进行修订的机制.
- 了解不同的路径可以实现合理的优化.
- 这项工作促进了改进的共价抑制剂的开发.
相关概念视频
Conjugate Addition of Enolates: Michael Addition
2.5K
The attack of a nucleophile at the β carbon of an α,β-unsaturated carbonyl compound is called conjugate addition. Conjugate addition reactions of active methylene compounds, such as β-diketones, β-keto esters, β-keto nitriles, and α-nitro ketones, are called Michael addition reactions.
2.5K
Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation
2.1K
Robinson annulation is a base-catalyzed reaction for the synthesis of 2-cyclohexenone derivatives from 1,3-dicarbonyl donors (such as cyclic diketones, β-ketoesters, or β-diketones) and α,β-unsaturated carbonyl acceptors. Named after Sir Robert Robinson, who discovered it, this reaction yields a six-membered ring with three new C–C bonds (two σ bonds and one π bond).
2.1K
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
6.0K
All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
6.0K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration
8.4K
The rate of acid-catalyzed hydration of alkenes depends on the alkene's structure, as the presence of alkyl substituents at the double bond can significantly influence the rate.
8.4K
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K


